4.2 Letter

Early experience with the Senhance®-laparoscopic/robotic platform in the US

Journal

JOURNAL OF ROBOTIC SURGERY
Volume 13, Issue 2, Pages 357-359

Publisher

SPRINGERNATURE
DOI: 10.1007/s11701-018-0893-3

Keywords

Laparoscopy; Robotic; Senhance; Mini-laparoscopy; Minimally invasive; TransEnterix

Categories

Ask authors/readers for more resources

The introduction of new robotic platforms will grow considerably in the near future as several manufacturers are in the developing stages of different innovative systems. One of the newest systems, the Senhance (R) platform (TransEnterix Surgical Inc., Morrisville, NC, USA) has been utilized in a variety of cases in Europe but only recently approved for limited clinical use in the United States. Here, we present our initial experience with this state-of-the-art system in patients requiring a variety of procedures.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available